MORF-088

N/A

Report date: 2023/09/08 17:41:52
NME

Base Information

Drug NameMORF-088
Drug Alias NameMORF-088
ClassificationSmall molecules
Mechanisms of Actionintegrin alpha V/beta 8 inhibitors
Targetsintegrin alpha V/beta 8
Therapy Area/IndicationsPrimary Myelofibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMorphic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphic Therapeutic Inc
Inactive CompaniesN/A
Active IndicationsPrimary Myelofibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A